PIMA546127

Neisseria gonorrhoeae Monoclonal Antibody (GC12-351.2), Invitrogen™

Manufacturer: Fischer Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 PIMA546127-Each-of-1 In Stock ₹ 92,115.00

PIMA546127 - Each of 1

₹ 92,115.00

In Stock

Quantity

1

Base Price: ₹ 92,115.00

GST (18%): ₹ 16,580.70

Total Price: ₹ 1,08,695.70

Antigen

Neisseria gonorrhoeae

Classification

Monoclonal

Concentration

0.70 mg/mL

Formulation

PBS with no preservative; pH 7.4

Host Species

Mouse

Purification Method

Protein G

Regulatory Status

RUO

Target Species

Bacteria

Product Type

Antibody

Isotype

IgG1

Applications

ELISA

Clone

GC12-351.2

Conjugate

Unconjugated

Gene Alias

Gonococci; N. gonorrhoeae

Immunogen

UV-inactivated Neisseria gonorrhoeae cells W-I, W-II, W-III.

Quantity

1 mg

Primary or Secondary

Primary

Content And Storage

-20° C, Avoid Freeze/Thaw Cycles

Form

Liquid

Related Products

Img

Fischer Scientific

PIMA546123

--

Img

Fischer Scientific

PIMA546109

--

Img

Fischer Scientific

PIMA546118

--

Img

Fischer Scientific

PIMA546183

--

Img

Fischer Scientific

PIMA546098

--

Img

Fischer Scientific

PIMA546149

--

Img

Fischer Scientific

PIMA546085

--

Img

Fischer Scientific

PIMA546181

--

Description

  • MA1-10716 detects Neisseria gonorrhoeae
  • MA1-10716 has been successfully used in ELISA applications
  • The MA1-10716 immunogen is UV-inactivated Neisseria gonorrhoeae cells W-I, W-II, W-III
  • Although pathogenic bacteria constitute only a small portion of bacterial species, infectious diseases caused by pathogenic bacteria affect millions of people worldwide
  • Diarrheal diseases, many of which are bacterial, are the second leading cause of death worldwide, claiming an estimated 5 million people annually
  • Furthermore, an estimated 3 million people die of tuberculosis annually, 500,000 people die of pertussis, and 25,000 die of typhoid
  • The ability of bacteria to utilize various food sources is a major factor behind their pervasiveness
  • Their vast numbers lead to rapid evolutionary changes resulting in emerging diseases as well as antibiotic-resistant strains of well known diseases
  • Examples of these are multi-drug resistant tuberculosis and methicillin-resistant Staphylococcus aureus
  • Research into the detection and treatment of these infectious disease agents will continue to expand in an effort to alleviate the effects of these diseases.